Irenic Capital Management LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1929389 NEW YORK, NY

Position in TBPH

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$44,810,186

-$6,847,151 QoQ

Shares Held

2,760,948

0.0% QoQ

Ownership

5.36%

of shares outstanding

% of Portfolio

4.48%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Irenic Capital Management LP holds $60,349,374 across 6 Biotechnology names. TBPH ranks #1 (74.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TBPH	Theravance Biopharma, Inc. This page	2,760,948	$44,810,186
2	JANX	Janux Therapeutics, Inc.	765,804	$10,644,675
3	QURE	uniQure N.V.	100,000	$1,635,000
4	AVIR	Atea Pharmaceuticals, Inc.	301,699	$1,623,140
5	FATE	Fate Therapeutics Inc	878,055	$1,053,666
6	VOR	Vor Biopharma Inc.	32,663	$582,707

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$44,810,186	2,760,948	0.0%	Shares	Sole	2026-05-18
2025-12-31	$51,657,337	2,760,948	0.0%	Shares	Sole	2026-02-17
2025-09-30	$40,309,840	2,760,948	0.0%	Shares	Sole	2025-11-14
2025-06-30	$30,453,256	2,760,948	0.0%	Shares	Sole	2025-08-14
2025-03-31	$24,655,265	2,760,948	0.0%	Shares	Sole	2025-05-15
2024-12-31	$25,980,520	2,760,948	0.0%	Shares	Sole	2025-02-14
2024-09-30	$22,253,240	2,760,948	0.0%	Shares	Sole	2024-11-14
2024-06-30	$23,412,839	2,760,948	0.0%	Shares	Sole	2024-08-14
2024-03-31	$24,765,703	2,760,948	0.0%	Shares	Sole	2024-05-14
2023-12-31	$31,033,055	2,760,948	0.0%	Shares	Sole	2024-02-14
2023-09-30	$23,826,981	2,760,948	0.0%	Shares	Sole	2023-11-14
2023-06-30	$28,575,811	2,760,948	-0.1%	Shares	Sole	2023-08-14
2023-03-31	$29,989,920	2,764,048	+62.5%	Shares	Sole	2023-05-15
2022-12-31	$19,084,513	1,700,937	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.